All articles tagged with #diagnostic technology
Scientists are exploring how body odour, caused by volatile organic compounds, can reveal health conditions like Parkinson's, diabetes, and infections. A notable case is Joy Milne, who can smell Parkinson's disease before diagnosis, inspiring research into non-invasive, scent-based diagnostic tests using advanced chemical analysis and bioengineered sensors. This approach could revolutionize early detection and treatment of various diseases.
Harvard Medical School researcher Johan Paulsson will lead a $104 million federal project funded by the Advanced Research Projects Agency for Health (ARPA-H) to study bacterial behavior and antibiotic resistance. The project aims to develop technology for improved diagnosis of bacterial infections, accelerate the discovery of new antibiotics, and enhance understanding of bacterial behavior. The research will involve scientists from 25 research groups across multiple institutions and will utilize microscopy, microfluidics, single-cell assays, and machine learning tools. The project has the potential to revolutionize the diagnosis and treatment of bacterial infections and address the growing threat of antibiotic resistance.
Fountain Life, a health technology company, has developed an AI coronary artery scan that can detect heart conditions before symptoms appear. The outpatient procedure involves a quick CAT scan of the heart, and the AI technology analyzes the results to provide insights into heart health, including plaque buildup. This early detection can enable individuals to take proactive measures to reverse heart disease. Fountain Life plans to expand its AI health services through partnerships with physicians, aiming to shift the healthcare paradigm to focus on early detection and prevention. The company also offers a full-body MRI using AI technology to detect various abnormalities. Cardiologists acknowledge the potential of AI in assisting with early detection and guiding treatment decisions. The AI artery scan carries minimal risk and aims to make early detection affordable and accessible.